NEW YORK (GenomeWeb News) — Vanderbilt University Medical Center is building a center that will study how proteomics and molecular markers can help develop diagnostics and drugs for cancer, the school said today.
Vanderbilt’s Center for Proteomics and Drug Actions is funded by a $1 million, five-year grant from the National Foundation for Cancer Research and will be linked with seven other university research centers in the US, UK, and in China, Vanderbilt said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.